Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
A ten-year comparison of Aristocrats ETFs highlights performance patterns, dividend consistency, and growth trajectory to aid selection.
27,377 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Oil prices jumped after fresh regional strikes disrupted Gulf supply routes, triggering a broader market rally in ene...
ExxonMobil stock near $150 highlights a broader earnings and cash-flow story that many retail investors overlook. Her...
Ethereum hovers near a pivotal price band that previously sparked a major move. On-chain activity is rising as trader...
U.S. forces say they destroyed 16 Iranian minelayers, signaling a flare-up near the Strait of Hormuz. Markets react a...
A federal judge blocked DOJ subpoenas aimed at Fed Chair Powell over a congressional hearing on the central bank’s HQ...
The National Association of Realtors reports a small February uptick in nar: pending home sales, but the index remain...
A Texas federal court voided the FinCEN anti-money laundering rule for title insurers, stopping broad reporting of no...
Markets react as Trump Eyes Climactic Battle signals a potential blockade at Hormuz, with oil markets and consumer bu...
Apollo Global Management posted strong 2025 revenue and raised its dividend, but the stock has fallen as private cred...
Cybersecurity stocks tumbled as Anthropic rolled out a new AI model, sending Palo Alto Networks and other peers lower...
In a high-stakes run-up to the 2026 elections, Donald Trump’s endorsements are reshaping GOP primaries and donor beha...